MedTrace Logo

MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

NCT00978770 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures such as MRI scans may help predict early response to treatment in patients with breast cancer undergoing chemotherapy.

PURPOSE: This phase II trial is studying MRI in predicting early response to chemotherapy in patients with locally advanced breast cancer.

Conditions

Interventions

DRUG

systemic chemotherapy

PROCEDURE

diffusion-weighted magnetic resonance imaging

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

PROCEDURE

magnetic resonance spectroscopic imaging

PROCEDURE

neoadjuvant therapy

Sponsors & Collaborators

  • Cancer Clinical Trials Unit, Scotland

    lead OTHER

Principal Investigators

  • Lindsay W. Turnbull, MD · Hull Royal Infirmary

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Completion
2010-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00978770 on ClinicalTrials.gov